MedGene Therapeutics
Silver Spring, US
Biotech
Founders & leadership
TK
Tae-erk KimDirector
JS
James SongDirector
YP
Yonghan ParkExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$1.1MraisedJun 2021 · 2 investors · Biotechnology
Rule 506(b)$51.5KraisedOct 2019 · 2 investors · Other Health Care
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.